Mario Gabelli Baxter International Inc Transaction History

Gamco Investors, Inc. Et Al

$9 Billion
Q3 2024

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Baxter International Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 158,673 shares of BAX stock, worth $5.32 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

158,673

Previous 156,968 1.09%

Holding current value

$5.32 Million

Previous $5.25 Million 14.74%

% of portfolio

0.07%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$32.85 - $40.26 $56,009 - $68,643	1,705 Added 1.09%	158,673 $6.02 Million
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $64,096 - $84,922	-1,950 Reduced 1.23%	156,968 $5.25 Million
Q1 2024 May 14, 2024	SELL	$37.88 - $43.77 $190,687 - $220,338	-5,034 Reduced 3.07%	158,918 $6.79 Million
Q3 2023 Nov 08, 2023	BUY	$37.32 - $49.29 $4.54 Million - $5.99 Million	121,563 Added 286.78%	163,952 $6.19 Million
Q2 2023 Aug 10, 2023	SELL	$39.98 - $47.68 $140,329 - $167,356	-3,510 Reduced 7.65%	42,389 $1.93 Million
Q1 2023 May 12, 2023	SELL	$37.58 - $52.57 $72,116 - $100,881	-1,919 Reduced 4.01%	45,899 $1.86 Million
Q4 2022 Feb 13, 2023	SELL	$49.7 - $57.71 $318,577 - $369,921	-6,410 Reduced 11.82%	47,818 $2.44 Million
Q3 2022 Nov 10, 2022	BUY	$53.86 - $66.8 $116,068 - $143,954	2,155 Added 4.14%	54,228 $2.92 Million
Q2 2022 Aug 12, 2022	SELL	$63.83 - $80.0 $62,042 - $77,760	-972 Reduced 1.83%	52,073 $3.35 Million
Q1 2022 May 18, 2022	SELL	$76.85 - $89.45 $23,055 - $26,835	-300 Reduced 0.56%	53,045 $4.11 Million
Q1 2022 May 13, 2022	SELL	$76.85 - $89.45 $77,080 - $89,718	-1,003 Reduced 1.85%	53,345 $4.14 Million
Q4 2021 Feb 11, 2022	SELL	$74.57 - $87.19 $528,701 - $618,177	-7,090 Reduced 11.54%	54,348 $4.67 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $201,687 - $228,589	2,734 Added 4.66%	61,438 $4.94 Million
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $144,900 - $158,418	-1,800 Reduced 2.98%	58,704 $4.73 Million
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $53,466 - $60,221	-700 Reduced 1.14%	60,504 $5.1 Million
Q4 2020 Feb 05, 2021	SELL	$75.39 - $82.36 $60,764 - $66,382	-806 Reduced 1.3%	61,204 $4.91 Million
Q3 2020 Nov 06, 2020	SELL	$78.33 - $90.73 $308,385 - $357,204	-3,937 Reduced 5.97%	62,010 $4.99 Million
Q2 2020 Aug 13, 2020	SELL	$78.66 - $94.14 $1.63 Million - $1.95 Million	-20,710 Reduced 23.9%	65,947 $5.68 Million
Q1 2020 May 14, 2020	SELL	$71.57 - $93.3 $136,841 - $178,389	-1,912 Reduced 2.16%	86,657 $7.04 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $55,684 - $64,214	-726 Reduced 0.81%	88,569 $7.41 Million
Q3 2019 Nov 01, 2019	SELL	$81.4 - $89.78 $480,260 - $529,702	-5,900 Reduced 6.2%	89,295 $7.81 Million
Q2 2019 Aug 02, 2019	SELL	$73.44 - $82.41 $311,385 - $349,418	-4,240 Reduced 4.26%	95,195 $7.8 Million
Q1 2019 May 02, 2019	SELL	$64.48 - $81.31 $374,951 - $472,817	-5,815 Reduced 5.52%	99,435 $8.09 Million
Q4 2018 Jan 30, 2019	BUY	$61.45 - $77.8 $841,865 - $1.07 Million	13,700 Added 14.96%	105,250 $6.93 Million
Q3 2018 Nov 02, 2018	SELL	$70.71 - $77.75 $134,349 - $147,725	-1,900 Reduced 2.03%	91,550 $7.06 Million
Q2 2018 Aug 10, 2018	SELL	$63.43 - $75.41 $180,775 - $214,918	-2,850 Reduced 2.96%	93,450 $6.9 Million
Q1 2018 May 09, 2018	SELL	$62.56 - $72.26 $162,656 - $187,876	-2,600 Reduced 2.63%	96,300 $6.26 Million
Q4 2017 Feb 02, 2018	SELL	$61.45 - $66.05 $1.25 Million - $1.35 Million	-20,400 Reduced 17.1%	98,900 $6.39 Million
Q3 2017 Nov 01, 2017	BUY	$59.5 - $64.61 $7.1 Million - $7.71 Million	119,300	119,300 $7.49 Million

Others Institutions Holding BAX

# of Institutions

1,008

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account